HROW
HarrowDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
HROW vs peer average
27/100
HROW vs. peer average (D vs. C)
Grade spread
A 2 · B 3 · C 1 · D 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
AUPH is the first available peer comparator.
AUPH is closer on market cap than on business mix; it is a loose specialty-biopharma comparison rather than a direct ophthalmic commercial peer, so relative valuation read-through is limited.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
HROW
Harrow
AUPH
Aurinia
Grade
D
B
Momentum
9
48
Value
50
65
Sentiment
82
57
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs AUPH
HROW / AUPH
Grade Position
Below peers
HROW vs. peer average (D vs. C)
27/100
Momentum
9
AUPHValue
50
AUPHSentiment
82
HROWRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs HROW
AUPH is the first peer returned for this comparison set.